Nanobody-based CAR T cells targeting intracellular tumor antigens

Chimeric antigen receptor (CAR) T-cell immunotherapy has become one of the research hotspots in the treatment of malignant tumors nowadays. However, the available tumor surface antigens are limited in number. Most tumor-associated antigens are intracellular molecules that can’t be targeted by conven...

Full description

Bibliographic Details
Main Authors:	Haixia Li, Dani Zhong, Huiguan Luo, Wei Shi, Shenxia Xie, Hangbiao Qiang, Lichen Zhu, Li Gao, Jun Liu, Shuyang Sun, Ziqiang Ding, Xiaomei Yang, Xiaoling Lu
Format:	Article
Language:	English
Published:	Elsevier 2022-12-01
Series:	Biomedicine & Pharmacotherapy
Subjects:	CAR T-cell therapy Nanobody TCR-like antibody Intracellular tumor antigen
Online Access:	http://www.sciencedirect.com/science/article/pii/S0753332222013087

Internet

http://www.sciencedirect.com/science/article/pii/S0753332222013087

Nanobody-based CAR T cells targeting intracellular tumor antigens

Internet

Similar Items